Pervasis Buyout Increases Shire's Expertise In Regenerative Medicine Specialty pharma says it will position ESRD candidate Vascugel for success, just as Shire is doing with Dermagraft, acquired in last year's buyout of Advanced BioHealing.
BioLineRx, Israel's Biotech Incubator, Nearing Major Inflection Points Funded in part by the Israeli government, BioLineRx believes it is about to score big with a cardiology drug being developed under FDA's regulatory pathway for devices, as well as a schizophrenia candidate that could improve patients' cognition.
Provigil Generic Exclusivity Decision "Eviscerates" Hatch-Waxman, FTC Says In a strongly worded amicus brief filed in Mylan's lawsuit against FDA, the Federal Trade Commission says it would have required different remedies in clearing Teva's acquisition of Cephalon last year had it known the Israel-based firm would receive sole 180-day marketing exclusivity for modafinil.
German Parliament Considers Lowering Mandatory Drug Rebate Level The German Upper House has proposed reducing the obligatory rebate manufacturers of original drug products must give health insurers and closing a loophole in the law on generic drug discount contracts.
"The Pink Sheet" DAILY - Daily, in-depth analysis of the key developments shaping the biopharma industry. Not a subscriber? To register for a free trial, click here